
FDA Approves Tryptyr Eye Drops for Dry Eye Disease
By Stephanie Brown HealthDay Reporter MONDAY, June 2, 2025 (HealthDay News) The U.S. Food and Drug Administration has approved the first-in-class TRPM8 receptor agonist Tryptyr (acoltremon ophthalmic solution) for the treatment of signs and symptoms of dry eye disease. Currently, dry eye disease treatment options are limited due to slow therapeutic onset, patient dissatisfaction, and…